The Scientist

» drug development, evolution and ecology

Most Recent

image: Allergan Set to Buy Vitae

Allergan Set to Buy Vitae

By | September 16, 2016

The Irish drugmaker has made a $639 million dollar offer to buy the US-based biopharma.

0 Comments

image: Stingrays Chew Too

Stingrays Chew Too

By | September 15, 2016

Researchers observe stingrays moving their jaws to grind up prey, a behavior thought to be restricted to mammals.

0 Comments

image: Week in Review: September 5–9

Week in Review: September 5–9

By | September 9, 2016

Environmental magnetite in the human brain; prion structure takes shape; watching E. coli evolve in real time; learning from others’ behavior 

0 Comments

image: Giant Petri Dish Displays Evolution in Space and Time

Giant Petri Dish Displays Evolution in Space and Time

By | September 8, 2016

As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.

7 Comments

image: Zika Update

Zika Update

By | September 7, 2016

Virus’s genome to aid in diagnoses; bees caught in crossfire of mosquito sprays; Zika spreads in Asia; US Congress revisits Zika funding

1 Comment

image: A Tribe of Hornbill Hunters Turns to Conservation

A Tribe of Hornbill Hunters Turns to Conservation

By | September 1, 2016

An indigenous community in northeastern India is a crucial part of the effort to save these majestic forest birds from extinction.

1 Comment

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: The Challenges of Rare-Disease Research

The Challenges of Rare-Disease Research

By | September 1, 2016

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

0 Comments

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: Pfizer to Buy Medivation for $14 Billion

Pfizer to Buy Medivation for $14 Billion

By | August 22, 2016

The pharma giant is purchasing the San Francisco–based cancer drugmaker to boost its oncology portfolio.

0 Comments

Popular Now

  1. Unstructured Proteins Help Tardigrades Survive Desiccation
  2. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  3. Opinion: On “The Impact Factor Fallacy”
  4. Inflammation Drives Gut Bacteria Evolution
Business Birmingham